Global Biosimilars Market (2020-2026)

Market Forecast by Product (insulin, follitropin, calcitonin, glucagon, teriparatide and others), by Indication (oncology, offsite treatment, chronic disorder, autoimmune disorders, blood disorders, infectious diseases and others), by Manufacturing (outsourced and in-house) and by Regions (North America, Europe, Asia Pacific, Latin America, Middle East and Africa) and Competitive Landscape

Product Code: ETC037266 Publication Date: Nov 2020 Product Type: Report
Publisher: 6Wresearch No. of Pages: 300 No. of Figures: 90 No. of Tables: 30

The global Biosimilars market is anticipated to flourish with significant and strong growth potential in the coming time zone as a result of an increase in the genomic activities for serving best-in-class healthcare services and is expected to be of great importance for the growth and development of the healthcare industry especially in the developing economies across the world. A rise in the legacies passed by the drug administration across the world and the manufacture of medicines with same biologics already been made, biosimilars are gaining popularity being an alternative available for already existing biologics with either the same or greater benefit reaper capability and as a result is expected to be of great importance for the growth in the coming timeframe. With the thirst of providing superior pharmaceuticals to the population being increasing, the value of pharma industry is also witnessing a ramp up. A rapid rise in biological science backed by the massive development of the science and technology in the developed and developing economies across the globe has posed a lot of opportunities on the face of the growth and development of biotechnology and life sciences and as a result, is leading to an increase in the growth of the need for biosimilars drugs and as a result, is expected to pose sound growth prospects for the Global biosimilars market in the forthcoming years. This is posing bountiful opportunities for the growth of the Biosimilars market and is expected to bring in great growth potential for the key market players in the coming time zone and be benefitted by a strong business growth as a result of an increase in the use of Biosimilars especially for the treatment of chronic respiratory Products such as asthma and bronchitis.

With the increase in the deployment of the product as a result of an increase in the unveiling of the true potential and the benefits which can be reaped by the product deployment, along with the potential health benefits which can be reaped by the injection of the product into the body of the suspect is anticipated to spur the global Biosimilars market in the forthcoming years.

According to 6Wresearch, the Global Biosimilars Market size is anticipated to register growth during 2020-26. The outbreak of the global pandemic COVID-19 has no doubt, been proven evident in bringing about a revolution in the global Biosimilars market. A rise in the number of covid suspects has led to an increase in the risk of asthma and is leading to a rise in the respiratory health issues among the ones suspected also. As an advisory aspect and a precautionary measure, the government and the healthcare sector along with are taking in initiatives for the deployment of biosimilars drugs to make the stock of medicines available at the time of Product emergency. No doubt, that the pharmaceutical industry has witnessed a skyrocketing growth due to the outbreak of the global and this is anticipated to be of great benefit for the growth and development of biologic drugs in the market globally in the coming time zone and is expected to be of great importance for the healthcare providers to seek fortunate business growth. Henceforth, the outbreak of the COVID-19 pandemic has led to shape up of the market competitive landscape of the global biosimilars market in the forthcoming years. A rise in the number of covid patients has led to an increase in the demand for biosimilars and is expected to of great importance for the growth of the global biosimilars market.

The Global Biosimilars market report thoroughly covers the market by Product, Indication, Manufacturing, and key regions including the Asia Pacific, Latin America, Middle East, Europe, North America and Africa. The Global Biosimilars market outlook report provides an unbiased and detailed analysis of the on-going Global Biosimilars market trends, opportunities/high growth areas, and market drivers which would help the stakeholders to devise and align their market strategies according to the current and future market dynamics.

 

Key Highlights of the Report:

  • Global Biosimilars Market Overview
  • Global Biosimilars Market Outlook
  • Global Biosimilars Market Forecast
  • Historical Data of Global Biosimilars Market Revenues & Volume for the Period 2016-2019
  • Global Biosimilars Market Size and Global Biosimilars Market Forecast of Revenues & Volume, Until 2026
  • Historical Data of Global Biosimilars Market Revenues & Volume, by Product, for the Period 2016-2019
  • Market Size & Forecast of Global Biosimilars Market Revenues & Volume, by Product, Until 2026
  • Historical Data of Global Biosimilars Market Revenues & Volume, by Indication, for the Period 2016-2019
  • Market Size & Forecast of Global Biosimilars Market Revenues & Volume, by Indication, Until 2026
  • Historical Data of Global Biosimilars Market Revenues, by Manufacturing, for the Period 2016-2019
  • Market Size & Forecast of Global Biosimilars Market Revenues, by Manufacturing, Until 2026
  • Historical Data of Global Biosimilars Market Revenues, by Regions, for the Period 2016-2019
  • Market Size & Forecast of Global Biosimilars Market Revenues, by Regions, Until 2026
  • Historical Data of Asia Pacific Biosimilars Market Revenues, for the Period 2016-2019
  • Market Size & Forecast of Asia Pacific Biosimilars Market Revenues, Until 2026
  • Historical Data of Latin America Biosimilars Market Revenues, for the Period 2016-2019
  • Market Size & Forecast of Latin America Biosimilars Market Revenues, Until 2026
  • Historical Data of Europe Biosimilars Market Revenues, for the Period 2016-2019
  • Market Size & Forecast of Europe Biosimilars Market Revenues, Until 2026
  • Historical Data of Middle East Biosimilars Market Revenues, for the Period 2016-2019
  • Market Size & Forecast of Middle East Biosimilars Market Revenues, Until 2026
  • Historical Data of North America Biosimilars Market Revenues, for the Period 2016-2019
  • Market Size & Forecast of North America Biosimilars Market Revenues, Until 2026
  • Historical Data of Africa Biosimilars Market Revenues, for the Period 2016-2019
  • Market Size & Forecast of Africa Biosimilars Market Revenues, Until 2026
  • Market Drivers and Restraints
  • Global Biosimilars Market Trends and Industry Life Cycle
  • Porter’s Five Force Analysis
  • Market Opportunity Assessment
  • Global Biosimilars Market Share, By Players
  • Global Biosimilars Market Share, By Regions
  • Global Biosimilars Market Overview on Competitive Benchmarking
  • Company Profiles
  • Key Strategic Recommendations

Markets Covered

The Global Biosimilars Market report provides a detailed analysis of the following market segments:

  • By Product:
    • Insulin
    • Follitropin
    • Calcitonin
    • Glucagon
    • Teriparatide
    • Others

  • By Indication:
    • Oncology
    • Offsite Treatment
    • Chronic Disorders
    • Blood Disorders
    • Infectious Diseases
    • Others

  • By Manufacturing:
    • Outsourced
    • In-house

  • By Regions:
    • Asia Pacific
    • North America
    • Latin America
    • Europe
    • Middle East
    • Africa

1.  Executive Summary

2.  Introduction

2.1. Report Description

2.2. Key Highlights

2.3. Market Scope & Segmentation

2.4. Research Methodology

2.5. Assumptions

3.  Global Biosimilars Market Overview

3.1.  Global Biosimilars Market Revenues, 2016-2026F

3.2.  Global Biosimilars Market Revenue Share, By Product, 2019 & 2026F

3.3.  Global Biosimilars Market Revenue Share, By Indication, 2019 & 2026F

3.4.  Global Biosimilars Market Revenue Share, By Manufacturing, 2019 & 2026F

3.5.  Global Biosimilars Market Revenue Share, By Regions, 2019 & 2026F

3.6.  Global Biosimilars Market Industry Life Cycle

3.7.  Global Biosimilars Market- Porter’s Five Forces

4.  Global Biosimilars Market Dynamics

4.1.  Impact Analysis

4.2.  Market Drivers

4.3.  Market Restraints

5.  Global Biosimilars Market Trends

6.  Global Biosimilars Market Overview, By Product

6.1.  Global Biosimilars Market Revenues, By Insulin, 2016-2026F

6.2.  Global Biosimilars Market Revenues, By Follitropin, 2016-2026F

6.3.  Global Biosimilars Market Revenues, By Glucagon, 2016-2026F

6.4.  Global Biosimilars Market Revenues, By Calcitonin, 2016-2026F

6.5.  Global Biosimilars Market Revenues, By Teriparatide, 2016-2026F

6.6.  Global Biosimilars Market Revenues, By Others, 2016-2026F

7.  Global Biosimilars Market Overview, By Indication

7.1.  Global Biosimilars Market Revenues, By Oncology, 2016-2026F

7.2.  Global Biosimilars Market Revenues, By Offsite Treatment, 2016-2026F

7.3.  Global Biosimilars Market Revenues, By Chronic Disorders, 2016-2026F

7.4.  Global Biosimilars Market Revenues, By Blood Disorders, 2016-2026F

7.5.  Global Biosimilars Market Revenues, By Infectious Disorders, 2016-2026F

7.6.  Global Biosimilars Market Revenues, By Others, 2016-2026F

8.  Global Biosimilars Market Overview, By Manufacturing

8.1.  Global Biosimilars Market Revenues, By Outsourced, 2016-2026F

8.2.  Global Biosimilars Market Revenues, By In-house, 2016-2026F

9.  Asia Pacific Biosimilars Market Overview

9.1. Asia Pacific Biosimilars Market Revenues, 2016-2026F

9.2. Asia Pacific Biosimilars Market Revenue Share, By Product, 2019 & 2026F

9.3. Asia Pacific Biosimilars Market Revenue Share, By Indication, 2019 & 2026F

9.4. Asia Pacific Biosimilars Market Revenue Share, By Manufacturing, 2019 & 2026F

9.5. Asia Pacific Biosimilars Market Revenue Share, By Countries, 2019 & 2026F

10.  North America Biosimilars Market Overview

10.1. North America Biosimilars Market Revenues, 2016-2026F

10.2. North America Biosimilars Market Revenue Share, By Product, 2019 & 2026F

10.3. North America Biosimilars Market Revenue Share, By Indication, 2019 & 2026F

10.4. North America Biosimilars Market Revenue Share, By Manufacturing, 2019 & 2026F

10.5. North America Biosimilars Market Revenue Share, By Countries, 2019 & 2026F

11.  Latin America Biosimilars Market Overview

11.1. Latin America Biosimilars Market Revenues, 2016-2026F

11.2. Latin America Biosimilars Market Revenue Share, By Product, 2019 & 2026F

11.3. Latin America Biosimilars Market Revenue Share, By Indication, 2019 & 2026F

11.4. Latin America Biosimilars Market Revenue Share, By Manufacturing, 2019 & 2026F

11.5. Latin America Biosimilars Market Revenue Share, By Countries, 2019 & 2026F

12.  Europe Biosimilars Market Overview

12.1. Europe Biosimilars Market Revenues, 2016-2026F

12.2. Europe Biosimilars Market Revenue Share, By Product, 2019 & 2026F

12.3. Europe Biosimilars Market Revenue Share, By Indication, 2019 & 2026F

12.4. Europe Biosimilars Market Revenue Share, By Manufacturing, 2019 & 2026F

12.5. Europe Biosimilars Market Revenue Share, By Countries, 2019 & 2026F

13.  Middle East Biosimilars Market Overview

13.1. Middle East Biosimilars Market Revenues, 2016-2026F

13.2. Middle East Biosimilars Market Revenue Share, By Product, 2019 & 2026F

13.3. Middle East Biosimilars Market Revenue Share, By Indication, 2019 & 2026F

13.4. Middle East Biosimilars Market Revenue Share, By Manufacturing, 2019 & 2026F

13.5. Middle East Biosimilars Market Revenue Share, By Countries, 2019 & 2026F

14.  Africa Biosimilars Market Overview

14.1. Africa Biosimilars Market Revenues, 2016-2026F

14.2. Africa Biosimilars Market Revenue Share, By Product, 2019 & 2026F

14.3. Africa Biosimilars Market Revenue Share, By Indication, 2019 & 2026F

14.4. Africa Biosimilars Market Revenue Share, By Manufacturing, 2019 & 2026F

14.5. Africa Biosimilars Market Revenue Share, By Countries, 2019 & 2026F

15. Global Biosimilars Market Competitive Landscape

15.1. Global Biosimilars Market, By Companies, 2019

15.2. Asia Pacific Biosimilars Market, By Companies, 2019

15.3. North America Biosimilars Market, By Companies, 2019

15.4. Latin America Biosimilars Market, By Companies, 2019

15.5. Europe Biosimilars Market, By Companies, 2019

15.7. Middle East Biosimilars Market, By Companies, 2019

15.8. Africa Biosimilars Market, By Companies, 2019

16.  Company Profiles

17.  Key Strategic Recommendations

Pricing
  • Single User License
    $ 4,200
  • Department License
    $ 4,650
  • Site License
    $ 5,100
  • Global License
    $ 5,500